Comparing the current results to its competitors, Revvity Inc reported Revenue increase in the 2 quarter 2026 by 1.31 % year on year. The revenue growth was below Revvity Inc's competitors' average revenue growth of 3.22 %, achieved in the same quarter.
April 15, 2024
Revvity, Inc. (NYSE: RVTY), based in Waltham, Massachusetts, is advancing its software and informatics division, Revvity Signals, with the introduction of two innovative software solutions - Signals SynergyTM and Signals ClinicalTM. Requiring a shift from traditional communication and data analysis methods, these solutions seek to redefine the relationship between pharmaceutical and clinical trial industries and their contract partners.Revvity Signals newly announced software, Signals SynergyTM, aims to overcome collaboration barriers and enhance project management between pharmaceutical and biotechnology sponsors and their external contract partners. The software offers improved data exchange functionality...
Schrodinger Inc is a computational drug discovery company that utilizes physics-based solutions to accelerate the discovery and development of new drugs. Their business model involves providing software and services to pharmaceutical and biotechnology companies, enabling them to optimize and streamline their drug discovery processes. By leveraging their unique expertise in computational chemistry and molecular modeling, Schrodinger aims to empower their clients in the pursuit of efficient and effective drug development.
Standard Biotools Inc operates as a biotechnology company that specializes in the development and distribution of standard laboratory tools and reagents. They offer a diverse range of high-quality products including lab equipment, molecular diagnostics, and research reagents to meet the needs of scientists and researchers in the life sciences industry. With a customer-centric approach, Standard Biotools aims to provide reliable and affordable solutions to support advancements in scientific research and discovery.
Rapid Micro Biosystems Inc has a business model centered around providing automated microbial detection and enumeration solutions for pharmaceutical companies, ensuring streamlined and efficient quality control processes. Their innovative technology enables rapid detection of microbial contamination in products, reducing the need for manual intervention and accelerating time-to-results for manufacturers.
Bruker Corporation operates as a manufacturer and supplier of scientific instruments and analytical solutions for a wide range of industries and research fields.
Bio-Rad Laboratories Inc operates as a global leader in life sciences and clinical diagnostics by focusing on the development, manufacturing, and distribution of a diverse array of products and solutions. Their business model emphasizes innovation, providing advanced tools and technologies that empower scientists and healthcare professionals to effectively analyze biological materials. By delivering high-quality solutions, Bio-Rad aims to facilitate scientific breakthroughs and enhance patient care in various healthcare settings.
Sources:
Revvity Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Revvity Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
